DABMA: A Derivative of ABMA with Improved Broad-Spectrum Inhibitory Activity of Toxins and Viruses.

MLA

Wu, Yu, et al. “DABMA: A Derivative of ABMA with Improved Broad-Spectrum Inhibitory Activity of Toxins and Viruses.” ACS Medicinal Chemistry Letters, vol. 10, no. 8, Aug. 2019, pp. 1140–47. EBSCOhost, https://doi.org/10.1021/acsmedchemlett.9b00155.

APA

Wu, Y., Pons, V., Noël, R., Kali, S., Shtanko, O., Davey, R. A., Popoff, M. R., Tordo, N., Gillet, D., Cintrat, J.-C., & Barbier, J. (2019). DABMA: A Derivative of ABMA with Improved Broad-Spectrum Inhibitory Activity of Toxins and Viruses. ACS Medicinal Chemistry Letters, 10(8), 1140–1147. https://doi.org/10.1021/acsmedchemlett.9b00155

Chicago

Wu, Yu, Valérie Pons, Romain Noël, Sabrina Kali, Olena Shtanko, Robert A. Davey, Michel R. Popoff, et al. 2019. “DABMA: A Derivative of ABMA with Improved Broad-Spectrum Inhibitory Activity of Toxins and Viruses.” ACS Medicinal Chemistry Letters 10 (8): 1140–47. doi:10.1021/acsmedchemlett.9b00155.